Literature DB >> 17443127

Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.

Matthew L Banks1, Paul W Czoty, H Donald Gage, Michael C Bounds, Pradeep K Garg, Sudha Garg, Michael A Nader.   

Abstract

Although serotonin (5-HT) can interact with dopamine (DA) systems to modulate the subjective and reinforcing effects of psychostimulants such as cocaine and 3,4-methyldioxymethamphetamine (MDMA, ecstasy), the long-term effects of exposure to psychostimulants on brain 5-HT systems are not well characterized. The present study assessed 5-HT transporter (SERT) availability using positron emission tomography (PET) in rhesus monkeys with the SERT-specific radioligand [(11)C]3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile (DASB). SERT availability was assessed in regions of interest including the caudate nucleus, putamen, anterior cingulate cortex, and cerebellum. [(11)C]DASB distribution volume ratios (DVRs) were calculated using the cerebellum as the reference region. DVRs were calculated in control monkeys and in cocaine or MDMA self-administering monkeys approximately 24 h after the last self-administration (SA) session. SERT availability did not differ between monkeys with a history of MDMA SA and control monkeys in any region examined. In contrast, monkeys with a history of cocaine SA showed significantly higher levels of SERT availability in the caudate nucleus and putamen compared to control subjects. These results suggest that chronic SA of cocaine, but not MDMA, leads to alterations in serotonergic function in brain areas relevant to drug abuse. The higher level of SERT availability in cocaine-experienced monkeys may lead to a reduced inhibitory tone of 5-HT on the DA system, which may explain, in part, differences in the abuse liability between cocaine and MDMA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443127      PMCID: PMC2167630          DOI: 10.1038/sj.npp.1301420

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  60 in total

1.  Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients.

Authors:  L K Jacobsen; J K Staley; R T Malison; S S Zoghbi; J P Seibyl; T R Kosten; R B Innis
Journal:  Am J Psychiatry       Date:  2000-07       Impact factor: 18.112

2.  Influence of abstinence and conditions of cocaine access on the reinforcing strength of cocaine in nonhuman primates.

Authors:  Paul W Czoty; Jennifer L Martelle; Michael A Nader
Journal:  Drug Alcohol Depend       Date:  2006-05-30       Impact factor: 4.492

3.  Effect of fenfluramine challenge on cocaine craving in addicted male users.

Authors:  L Buydens-Branchey; M Branchey; J Hudson; M Rothman; P Fergeson; C McKernin
Journal:  Am J Addict       Date:  1998

4.  (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane.

Authors:  Xiaoying Wang; Michael H Baumann; Heng Xu; Marisela Morales; Richard B Rothman
Journal:  J Pharmacol Exp Ther       Date:  2005-06-03       Impact factor: 4.030

5.  Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.

Authors:  Una D McCann; Zsolt Szabo; Esen Seckin; Peter Rosenblatt; William B Mathews; Hayden T Ravert; Robert F Dannals; George A Ricaurte
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

6.  A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys.

Authors:  Joshua A Lile; Jason T Ross; Michael A Nader
Journal:  Drug Alcohol Depend       Date:  2004-12-08       Impact factor: 4.492

7.  Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.

Authors:  Matthew S Milak; R Todd Ogden; Daniel N Vinocur; Ronald L Van Heertum; Thomas B Cooper; J John Mann; Ramin V Parsey
Journal:  Biol Psychiatry       Date:  2005-01-01       Impact factor: 13.382

8.  Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.

Authors:  Peter S Talbot; W Gordon Frankle; Dah-Ren Hwang; Yiyun Huang; Raymond F Suckow; Mark Slifstein; Anissa Abi-Dargham; Marc Laruelle
Journal:  Synapse       Date:  2005-03-01       Impact factor: 2.562

9.  Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

Authors:  R B Rothman; M H Baumann; C M Dersch; D V Romero; K C Rice; F I Carroll; J S Partilla
Journal:  Synapse       Date:  2001-01       Impact factor: 2.562

10.  Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

Authors:  Jeffrey H Meyer; Sylvain Houle; Sandra Sagrati; Anna Carella; Doug F Hussey; Nathalie Ginovart; Verdell Goulding; James Kennedy; Alan A Wilson
Journal:  Arch Gen Psychiatry       Date:  2004-12
View more
  18 in total

1.  Nonhuman primate positron emission tomography neuroimaging in drug abuse research.

Authors:  Leonard Lee Howell; Kevin Sean Murnane
Journal:  J Pharmacol Exp Ther       Date:  2011-02-11       Impact factor: 4.030

2.  Serotonin transporter protein in autopsied brain of chronic users of cocaine.

Authors:  Junchao Tong; Jeffrey H Meyer; Isabelle Boileau; Lee-Cyn Ang; Paul J Fletcher; Yoshiaki Furukawa; Stephen J Kish
Journal:  Psychopharmacology (Berl)       Date:  2020-06-03       Impact factor: 4.530

Review 3.  The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.

Authors:  Yosta Vegting; Liesbeth Reneman; Jan Booij
Journal:  Psychopharmacology (Berl)       Date:  2016-08-28       Impact factor: 4.530

4.  Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use.

Authors:  Eileen K Sawyer; Jiyoung Mun; Jonathon A Nye; Heather L Kimmel; Ronald J Voll; Jeffrey S Stehouwer; Kenner C Rice; Mark M Goodman; Leonard L Howell
Journal:  Neuropsychopharmacology       Date:  2012-03-21       Impact factor: 7.853

Review 5.  Neuroimaging and drug taking in primates.

Authors:  Kevin S Murnane; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2011-03-01       Impact factor: 4.530

6.  Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.

Authors:  Samanta Yubero-Lahoz; K P C Kuypers; J G Ramaekers; Klaus Langohr; Magí Farré; Rafael de la Torre
Journal:  Psychopharmacology (Berl)       Date:  2014-12-20       Impact factor: 4.530

Review 7.  PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Authors:  Robert W Gould; Angela N Duke; Michael A Nader
Journal:  Neuropharmacology       Date:  2013-02-28       Impact factor: 5.250

Review 8.  Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.

Authors:  Leonard L Howell; Kevin S Murnane
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates.

Authors:  Stephanie M Groman; J David Jentsch
Journal:  Curr Opin Neurobiol       Date:  2013-03-22       Impact factor: 6.627

10.  Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.

Authors:  María Juliana Orejarena; Fernando Berrendero; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2009-06-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.